Find uplifting stories about heroes, innovations, and solutions
6 results for "neuroinflammation"
A Cambridge biotech just secured $5 million to fast-track a groundbreaking Alzheimer's treatment that targets brain inflammation instead of protein buildup. The therapy could help millions by addressing a root cause that's been overlooked for decades.
Researchers in Brazil discovered a naturally occurring molecule that shields brain cells from Parkinson's damage in mice. Unlike current treatments that only mask symptoms, this approach targets the root inflammation causing cell death.
Researchers at the University of Southern California have created compounds that could calm brain inflammation tied to Alzheimer's disease while preserving normal brain function. The breakthrough targets a specific enzyme elevated in people with the APOE4 gene, the strongest genetic risk factor for the disease.
Researchers discovered compounds that could reduce brain inflammation in Alzheimer's patients, especially those with the high-risk APOE4 gene. The breakthrough targets a specific enzyme while preserving healthy brain function.
A groundbreaking clinical trial has begun testing an oral medication that could slow Parkinson's disease progression by targeting inflammation in the brain. The drug has already shown a remarkable safety record across multiple disease trials.
Scientists using quantum computers just identified hidden causes of long COVID that traditional AI missed, opening doors to new treatments. This breakthrough shows how quantum technology could revolutionize personalized medicine for everyone.